Patient-focused intervention to improve long-term adherence to evidence-based medications: a randomized trial

SB Calvert, JM Kramer, KJ Anstrom, LA Kaltenbach… - American heart …, 2012 - Elsevier
BACKGROUND: Nonadherence to cardiovascular medications is a significant public health
problem. This randomized study evaluated the effect on medication adherence of linking …

Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome

C Melloni, KP Alexander, FS Ou, NMA LaPointe… - The American journal of …, 2009 - Elsevier
Use of evidence-based medicine (EBM) improves outcomes after acute coronary syndromes
(ACS), yet patients often discontinue prescribed therapies after discharge. Although such …

Drug discontinuation effects are part of the pharmacology of a drug

MM Reidenberg - Journal of Pharmacology and Experimental …, 2011 - ASPET
Most reviews of drug withdrawal effects focus on drugs of potential abuse such as opioids,
benzodiazepines, etc. Abrupt discontinuation of many other drugs used in medicine cause …

National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance

JM Kramer, B Hammill, KJ Anstrom, D Fetterolf… - American heart …, 2006 - Elsevier
BACKGROUND: Quality measures of evidence-based medications post–myocardial
infarction have focused on prescription at hospital discharge. Yet survival benefits of these …

Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes

N Rieckmann, IM Kronish, D Haas, W Gerin… - American heart …, 2006 - Elsevier
BACKGROUND: Even mild depressive symptoms during hospitalization are an independent
risk factor for mortality after acute coronary syndromes (ACS). The mortality risk is highest for …

Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry

KAA Fox, FA Anderson Jr, SG Goodman… - Nature Clinical Practice …, 2008 - nature.com
Background The time course of events after acute coronary syndromes might influence the
timing and duration of therapeutic interventions. We investigated the impact of risk status …

Proportion and risk indicators of nonadherence to antihypertensive therapy: a meta-analysis

M Lemstra, MW Alsabbagh - Patient preference and adherence, 2014 - Taylor & Francis
Purpose The World Health Organization (WHO) concluded that poor adherence to treatment
is the most important cause of uncontrolled high blood pressure, with approximately 75% of …

Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study

EV Ganse, L Laforest, E Alemao, G Davies… - … medical research and …, 2005 - Taylor & Francis
Background: Few studies have been conducted in actual clinical practice settings to
evaluate the ways in which dyslipidemia is managed using lipid-modifying therapies …

[HTML][HTML] The effect of text message reminders on medication adherence among patients with coronary heart disease: a systematic review and meta-analysis

YY Zhao, FP Dang, TT Zhai, HJ Li, RJ Wang, JJ Ren - Medicine, 2019 - journals.lww.com
Background: To determine the effectiveness of text message reminders (TMR) on
medication adherence (MA) and to investigate the effects of TMR on clinical outcomes …

Use of medications for secondary prevention after coronary bypass surgery compared with percutaneous coronary intervention

MA Hlatky, MD Solomon, D Shilane, TK Leong… - Journal of the American …, 2013 - jacc.org
Objectives: This study sought to compare use of evidence-based secondary preventive
medications after coronary bypass surgery (CABG) and percutaneous coronary intervention …